Canada· CA-DIN-02237548
TWINRIX JUNIOR
A kombinationen (hepatitis a + hepatitis b) product containing hepatitis b surface antigen (recombinant) + hepatitis a virus, inactivated, registered in Canada by GLAXOSMITHKLINE INC. The same ATC class is registered in 11 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Kombinationen (hepatitis a + hepatitis b) is registered in 11 of 19 countries.
Countries holding a registration under ATC J07BC20 (kombinationen (hepatitis a + hepatitis b)), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 7 of them publish a price we can compare per daily dose
Kombinationen (hepatitis a + hepatitis b) · ATC J07BC20
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- HEPATITIS B SURFACE ANTIGEN (RECOMBINANT) + HEPATITIS A VIRUS, INACTIVATED
- Manufacturer
- GLAXOSMITHKLINE INC
- Country
- Canada (CA)
- ATC code
- J07BC20
- ATC class
- Kombinationen (Hepatitis A + Hepatitis B)
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under J07BC20
Kombinationen (hepatitis a + hepatitis b), as other registers publish it.
- IcelandAmbirixGlaxoSmithKline Biologicals S.A.*
- DenmarkAmbirixGlaxoSmithKline Biologicals S.A.
- BelgiumAmbirixGlaxoSmithKline Biologicals
- PolandAmbirixGlaxoSmithKline Biologicals S.A.
- FinlandAmbirixGlaxoSmithKline Biologicals S.A.
- CzechiaAMBIRIXGlaxoSmithKline Biologicals S.A., Rixensart
- CzechiaAMBIRIXGlaxoSmithKline Biologicals S.A., Rixensart
- CzechiaAMBIRIXGlaxoSmithKline Biologicals S.A., Rixensart
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/691683b3-023b-44cf-8117-f01ca790d6b6 GET /v1/drugs/691683b3-023b-44cf-8117-f01ca790d6b6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02237548",
"form": "SUSPENSION",
"class": "Human",
"routes": [
"INTRAMUSCULAR"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "J07BC20",
"schedule": [
"Schedule D"
],
"drug_code": "60885",
"strengths": [
"10 MCG",
"360 UNIT"
],
"ahfs_class": null,
"substances": [
"HEPATITIS B SURFACE ANTIGEN (RECOMBINANT)",
"HEPATITIS A VIRUS, INACTIVATED"
],
"product_categorization": null
}See everything about kombinationen (hepatitis a + hepatitis b).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.